Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...

To reduce the risks of drug development, KaiPharm, based in Seoul, South Korea, has developed KMAP, which combines artificial intelligence (AI) with transcriptome profiling to generate deep ...

KMAP projects DNA sequences—known as k-mers ... active at promoter and enhancer regions once ETV6 was degraded (fig. 2). Notably, the study also identified an uncharacterized DNA motif ...